Are there any restrictions when it comes to promoting prescription medicines to hospital buying groups or hospital administrators? How are they categorized on the consumer vs patient vs HCP spectrum?
C
charlton
@charlton
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Promoting to hospital buying groups/administrators -
Definition of a pragmatic trialForgive my ignorance but as pragmatic trials are relatively new, it would be helpful to know how you define "pragmatic trial" and where they fit in the taxonomy of clinical research (e.g. experimental vs observational; and if observational, analytical vs descriptive).
Thanks. -
Conference booth regulationsCan a pharmaceutical company have a product branded booth at a conference where the disease state in question is off label? For example, could a company promoting an antihypertensive have a booth at an obesity conference?
-
FYI for a price update?We have a recently approved APS that includes the price of the product. If the price changes, and we make just that one change to the piece, can this be handled with an FYI email?
-
Brand name onlyThe recent PAAB Advisory on Small Space Ads is very welcome. However, it doesn't quite answer a question I have. If I have a static (one frame) banner ad, and I only want to direct the viewer to a landing page where we offer further information and samples, can I use the brand name only, without the indication and fair balance? There would be no claims.
-
Patient case studiesThanks for your reply. However, I'm still not clear about whether the patient is required to have been one of the patients included in the trial included in the PM.
-
Patient case studiesAre real patient case studies, used to illustrate before and after effects, which were not taken from the efficacy studies in the PM, acceptable in a branded piece?